Entremed reports patent issuance for its lead drug candidate ENMD-2076

[News]

EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of a variety of cancers, today announced the issuance by the Chinese State Intellectual Property Office of Patent Certificate No. ZL 200680044656.7.

More... (http://www.news-medical.net/news/20130507/Entremed-reports-patent-issuance-for-its-lead-drug-candidate-ENMD-2076.aspx)